Gilead Sciences, Inc. (GILD)
145.14
-3.08
(-2.08%)
USD |
NASDAQ |
Mar 05, 16:00
144.13
-1.01
(-0.70%)
After-Hours: 04:53
Gilead Sciences Research and Development Expense (Annual) : 5.688B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| Johnson & Johnson | 14.83B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Arcellx, Inc. | 157.61M |
| Moderna, Inc. | 2.917B |